Multi-omics analysis defines core genomic alterations in pheochromocytomas and paragangliomas

161Citations
Citations of this article
157Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Pheochromocytomas and paragangliomas (PCCs/PGLs) are neural crest-derived tumours with a very strong genetic component. Here we report the first integrated genomic examination of a large collection of PCC/PGL. SNP array analysis reveals distinct copy-number patterns associated with genetic background. Whole-exome sequencing shows a low mutation rate of 0.3 mutations per megabase, with few recurrent somatic mutations in genes not previously associated with PCC/PGL. DNA methylation arrays and miRNA sequencing identify DNA methylation changes and miRNA expression clusters strongly associated with messenger RNA expression profiling. Overexpression of the miRNA cluster 182/96/183 is specific in SDHB-mutated tumours and induces malignant traits, whereas silencing of the imprinted DLK1-MEG3 miRNA cluster appears as a potential driver in a subgroup of sporadic tumours. Altogether, the complete genomic landscape of PCC/PGL is mainly driven by distinct germline and/or somatic mutations in susceptibility genes and reveals different molecular entities, characterized by a set of unique genomic alterations.

Cite

CITATION STYLE

APA

Castro-Vega, L. J., Letouzé, E., Burnichon, N., Buffet, A., Disderot, P. H., Khalifa, E., … Gimenez-Roqueplo, A. P. (2015). Multi-omics analysis defines core genomic alterations in pheochromocytomas and paragangliomas. Nature Communications, 6. https://doi.org/10.1038/ncomms7044

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free